Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Mol Ther Oncolytics
; 19: 240-252, 2020 Dec 16.
Article
in En
| MEDLINE
| ID: mdl-33209979
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2020
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Estados Unidos